Study guide

3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols

Board Certified Specialist in Renal Nutrition CSR

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Kidney Disease Foundations

1.1 CDR CSR Exam Structure, Eligibility, Logistics & the 2023 Content Outline 1.2 Renal Anatomy, Physiology & Glomerular Hemodynamics 1.3 CKD Etiology, KDIGO Staging & Progression Risk

2 Chapter 2: Domain 1 — Anthropometric & Body Composition Assessment

2.1 Dry Weight Determination, Fluid Assessment & Interdialytic Weight Gain 2.2 Anthropometric Measurement Standards (Knee Height, Skinfolds, Frame Size) 2.3 Body Composition Analysis: BIA, BIS, DXA & Handgrip Dynamometry

3 Chapter 3: Domain 1 — Nutrition-Focused Physical Findings & PEW Assessment Tools

3.1 Protein-Energy Wasting (PEW) Diagnostic Criteria & Pathophysiology 3.2 Subjective Global Assessment (7-Point SGA) in Dialysis 3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols 3.4 Nutrition-Focused Physical Exam (NFPE) for Muscle & Fat Loss

4 Chapter 4: Domain 1 — Diet, Medical, Medication & Psychosocial History

4.1 Dietary Intake Assessment & Food Frequency Methods in CKD 4.2 Medical & Medication History: Drug–Nutrient Interactions and Supplements 4.3 Psychosocial, Social & Functional History in Renal Nutrition Assessment

5 Chapter 5: Domain 1 — Medical Tests & Procedures by Treatment Modality

5.1 Hemodialysis Clinical Assessment & Vascular Access Considerations 5.2 Peritoneal Dialysis & Peritoneal Glucose Absorption Assessment 5.3 AKI, CRRT & Pediatric Renal Disease Assessment

6 Chapter 6: Domain 1 — Nutrition Diagnosis: Terminology, Etiology & Reasoning

6.1 Standardized Nutrition Diagnostic Terminology (NCP) in Nephrology 6.2 Etiology & Root-Cause Analysis for Renal Nutrition Problems 6.3 Diagnostic Reasoning for Fluid, Mineral & Protein Imbalances

7 Chapter 7: Domain 1 — Nutrition Diagnosis in Complex Patients

7.1 Formulating Valid PES Statements in Complex Dialysis Patients 7.2 Differentiating PEW, Sarcopenia & Cachexia in CKD 7.3 Diagnostic Prioritization across Cardiorenal & Diabetic Nephropathy

8 Chapter 8: Domain 2 — Food & Nutrient Delivery: Protein & Energy

8.1 KDOQI 2020 Protein Targets: Non-Dialysis CKD (LPD vs. VLPD) 8.2 Protein Prescriptions for Hemodialysis and Peritoneal Dialysis 8.3 Energy Requirements, Carbohydrates & Plant-Dominant Diets (PLADO)

9 Chapter 9: Domain 2 — Electrolytes, Fluid, Acid–Base & Micronutrients

9.1 Potassium Management: Dietary Restriction, Leaching & K-Binders 9.2 Sodium & Fluid Prescriptions across Dialysis Modalities 9.3 Acid-Base Homeostasis & Bicarbonate Replacement Therapy 9.4 Micronutrient, Trace Mineral & Vitamin Supplementation in ESRD

10 Chapter 10: Domain 2 — Medications & Specialized Nutrition Support

10.1 CKD-MBD Pharmacology: Phosphorus Binders, Vitamin D & Calcimimetics 10.2 Anemia Management: Iron Homeostasis, IV Iron Protocols & ESAs 10.3 Enteral, IDPN & Intraperitoneal Amino Acid Nutrition Support

11 Chapter 11: Domain 2 — Treatments Across the Continuum: Transplant & Comorbidities

11.1 Kidney Transplant I: Candidacy, Living Donors & the Early Post-Transplant Period 11.2 Kidney Transplant II: Long-Term Care, Immunosuppressant Side Effects & Graft Protection 11.3 Diabetes Management Across CKD Stages: Glycemic Targets, Medications & MNT 11.4 GI & Cardiovascular Comorbidities: Gastroparesis, Constipation, Liver Disease, Lipids & Blood Pressure

12 Chapter 12: Domain 2 — Monitoring & Evaluation: Labs, Fluid & Nutrition Trends

12.1 Renal Laboratory Surveillance: Frequency, Target Ranges & Trending 12.2 Monitoring Fluid Balance, Blood Pressure & Cardiovascular Risk 12.3 Longitudinal Assessment of Nutritional Status & Weight Trajectories

13 Chapter 13: Domain 2 — Monitoring Dialysis Adequacy & Kinetics

13.1 Hemodialysis Adequacy: Urea Kinetic Modeling, spKt/V & URR 13.2 Peritoneal Dialysis Adequacy & Peritoneal Equilibration Test (PET) 13.3 Normalized Protein Catabolic Rate (nPCR / nPNA) Interpretation 13.4 Troubleshooting Inadequate Dialysis vs. Dietary Non-Adherence

14 Chapter 14: Domain 2 — Care Coordination, Communication & Education

14.1 Interdisciplinary Team Care, Patient Education & Counseling Ethics 14.2 Individualized & Group Education: Medicare MNT and KDE Benefits, Caregivers & Curricula 14.3 Interfacility Coordination of Care: Hospital Handoffs, Transfers, Transplant Centers & Modality Changes 14.4 Psychosocial Support & Resources: Food Assistance, Financial Programs, Rehabilitation & Peer Support

15 Chapter 15: Domain 3 — Regulations & Quality Management

15.1 CMS Conditions for Coverage: IDT, Dietitian Qualifications, Assessment & Plan-of-Care Timelines 15.2 QAPI Programs, PDSA Cycles & the ESRD Quality Incentive Program 15.3 Medicare ESRD Payment, ESRD Networks, EQRS & the Survey Measures Assessment Tool

16 Chapter 16: Domain 3 — Evidence-Based Practice: Guidelines, Research & Protocols

16.1 The KDOQI 2020 Nutrition in CKD Guideline (NKF–Academy EAL): Grades & Key Statements 16.2 KDIGO & Companion Guidelines: CKD 2024, CKD-MBD, Anemia 2026, Diabetes, BP, Lipids & AKI 16.3 Appraising Current Research: Study Designs, Bias, Statistics & Landmark Renal Trials 16.4 Clinical Protocols & Algorithms: Dietitian-Managed MBD, Anemia, Potassium & Nutrition-Support Pathways

3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols

Key Takeaways Explain This Topic AI

The Malnutrition Inflammation Score (MIS) is a comprehensive, 10-component quantitative scoring system (range 0–30) developed by Kalantar-Zadeh that integrates the subjective elements of SGA with objective measures: BMI, serum albumin, and serum TIBC.

In the MIS framework, serum Total Iron Binding Capacity (TIBC) serves as an objective, non-invasive surrogate for transferrin and visceral protein reserves, dropping sharply during protein depletion and cytokine-driven inflammation.

Each of the 10 MIS components is scored from 0 (normal) to 3 (severely abnormal), and higher totals (studies often use cutoffs such as above 8) indicate more severe protein-energy wasting and inflammation.

Higher MIS scores independently predict ESA hyporesponsiveness, hospitalization and mortality in dialysis cohorts; KDOQI 2020 (statement 1.5.2, grade 2C) says the MIS may be used in maintenance hemodialysis and after transplant.

Compared to the qualitative 7-point SGA and the categorical ISRNM PEW criteria, the MIS offers a granular, continuous numerical scale superior for tracking longitudinal responses to nutritional and anti-inflammatory therapies.

Last updated: September 2026

Malnutrition Inflammation Score (MIS) & Scoring Protocols

Core Clinical Principle: The Malnutrition Inflammation Score (MIS) is the first fully quantitative, nephrology-specific scoring system that directly links somatic protein-energy wasting with systemic microinflammation. By combining the historical and physical examination domains of Subjective Global Assessment with three objective markers—Body Mass Index, serum albumin, and serum total iron binding capacity (TIBC)—the MIS generates a continuous composite score (0 to 30) that offers unmatched prognostic accuracy for hospitalization and mortality in end-stage renal disease.

Developed in 2001 by Dr. Kamyar Kalantar-Zadeh and colleagues , the MIS was engineered to overcome the primary limitation of conventional nutritional tools: their inability to account for the Malnutrition-Inflammation Complex Syndrome (MICS) , also termed the Malnutrition-Inflammation-Atherosclerosis (MIA) syndrome. In dialysis patients, protein wasting and chronic microinflammation are inextricably linked; inflammation drives hypercatabolism and suppresses hepatic protein synthesis, while nutritional depletion impairs immunocompetence. The MIS captures both axes in a standardized, reproducible bedside instrument.

1. The 10 Components of the Malnutrition Inflammation Score

The MIS evaluates 10 distinct components , each assigned a score from 0 (normal / no impairment) to 3 (severe impairment) . Summing the individual scores yields an aggregate MIS ranging from 0 (optimal nutritional and non-inflammatory state) to 30 (extreme, life-threatening wasting and inflammation) .

Detailed Scoring Breakdown Across the 10 Components

# Component Score 0 (Normal) Score 1 (Mild) Score 2 (Moderate) Score 3 (Severe)

1 Dry Weight Change (over past 3–6 months) < 0.5 kg loss 0.5 to 1.0 kg loss > 1.0 kg loss, but < 5% of body weight ≥ 5% loss of body weight

2 Dietary Intake Good / habitual solid diet; normal intake Slightly suboptimal solid diet; minor anorexia Moderately suboptimal solid diet or full liquid diet Severe hypocaloric liquid diet or near-starvation

3 Gastrointestinal Symptoms None, or rare occasional symptoms Mild symptoms (occasional nausea, mild early satiety) Moderate symptoms (frequent nausea, vomiting, or diarrhea) Severe, daily intractable vomiting, anorexia, or diarrhea

4 Functional Capacity Normal functional capacity; vigorous/independent Difficulty with heavy work or strenuous ambulation Difficulty with light work; mostly sedentary lifestyle Bedridden or wheelchair-bound; dependent for ADLs

5 Comorbidity (CCI + Vintage) Mild/no comorbidity; on dialysis < 1 year Moderate comorbidity OR on dialysis 1 to 4 years Severe comorbidity OR on dialysis > 4 years Very severe comorbidity (e.g., severe CHF, metastatic cancer, sepsis)

6 Subcutaneous Fat Loss (orbital, triceps, biceps, chest) Normal; full fat cushions, normal pinch thickness Mild loss; slight decrease in skinfold thickness Moderate loss; hollow eye sockets, reduced fat pinch Severe loss; near-total absence of subcutaneous adipose tissue

7 Muscle Wasting (temple, clavicle, scapula, ribs, knee, interosseous) Normal muscle bulk; firm, convex contours Mild wasting; slight temple flattening, clavicle visible Moderate wasting; hollow temples, prominent clavicles/scapula Severe wasting; hollow scooped temples, skeletal 'coat-hanger' appearance

  • 8 Body Mass Index (BMI) ≥ 20.0 kg/m² 18.0 to 19.99 kg/m² 16.0 to 17.99 kg/m² < 16.0 kg/m²
  • 9 Serum Albumin ≥ 4.0 g/dL 3.5 to 3.9 g/dL 3.0 to 3.4 g/dL < 3.0 g/dL
  • 10 Serum TIBC (Total Iron Binding Capacity) ≥ 250 mg/dL 200 to 249 mg/dL 150 to 199 mg/dL < 150 mg/dL
  • 2. In-Depth Rationale for Biochemical Parameters in MIS

Unlike traditional SGA, which is purely qualitative, the inclusion of objective biochemical parameters in MIS provides vital diagnostic and prognostic power:

A. Serum Albumin Thresholds

Serum albumin is a negative acute-phase reactant with a circulating half-life of approximately 20 days . In maintenance dialysis, circulating albumin levels are regulated by a balance between hepatic synthesis, transcapillary escape, dialytic losses, and catabolism. Pro-inflammatory cytokines (IL-6, TNF-α) suppress hepatic albumin gene transcription while increasing vascular permeability. In the MIS, an albumin < 3.0 g/dL receives the maximum score of 3 , directly capturing severe visceral depletion and intense systemic inflammation.

B. Serum Total Iron Binding Capacity (TIBC) as a Visceral Protein & Inflammatory Marker

Many clinicians overlook the biochemical rationale for including TIBC in a nutritional assessment score:

Surrogate for Serum Transferrin: In clinical laboratories, transferrin is frequently not ordered directly due to cost. However, TIBC directly reflects circulating transferrin according to the established biochemical relationship: Serum Transferrin (mg/dL) ≈ Serum TIBC (mg/dL) * 0.7 to 0.8 (or conversely, TIBC ≈ Transferrin * 1.38 to 1.45 ).

Rapid Kinetic Response: Transferrin has a much shorter half-life ( ~8 days ) than albumin (~20 days), making TIBC a more agile and rapid responder to acute protein starvation and recovery.

Dual Nutritional and Inflammatory Indicator: Transferrin is a powerful negative acute-phase protein. During chronic microinflammation, elevated hepcidin and cytokine activity trap iron within the reticuloendothelial system while the liver drastically downregulates transferrin synthesis. A TIBC < 150 mg/dL (Score 3) signifies severe visceral protein depletion compounded by intense, unyielding cytokine activation.

3. Clinical Interpretation and Prognostic Stratification

Summing the 10 components yields an objective score that stratifies patients into actionable prognostic tiers: MIS RISK STRATIFICATION

  • [ 0 -------------- 5 ] [ 6 -------------- 8 ] [ 9 ----------------------------- 30 ]
  • Low Nutritional Risk Moderate Malnutrition Severe PEW & High Inflammation
  • Excellent visceral stores • Mild somatic/visceral loss • Profound muscle & fat wasting
  • Low systemic inflammation • Emerging inflammatory drive • High hs-CRP and Interleukin-6
  • High ESA responsiveness • Moderate ESA resistance • Severe ESA Hyporesponsiveness
  • Lowest risk • Warrants oral supplements • Highest hospitalization & death risk
  • Interpreting the Score (Teaching Bands)

The MIS has no single official cut point. Studies have used thresholds such as 5 or more, or above 8, and each additional point is associated with higher hospitalization and mortality risk. Use the bands below as a practical teaching guide, not as validated categories:

Score 0 to 5 (Lower Risk): Adequate somatic and visceral reserves and a low inflammatory burden.

Score 6 to 8 (Moderate Risk): Early, progressive PEW and emerging microinflammation. This is the critical therapeutic window for the renal dietitian: initiating oral nutritional supplements (ONS) or aggressive anti-inflammatory management at this stage can prevent progression to irreversible cachexia.

Score > 8 (Severe PEW & High Inflammatory Risk):

Erythropoietin Resistance: Scores > 8 correlate strongly with Erythropoietin Resistance Index (ERI) elevation. Patients require massively escalated doses of erythropoiesis-stimulating agents (ESAs) to maintain target hemoglobin because inflammatory cytokines blunt erythroid progenitor proliferation and disrupt iron utilization.

Mortality and Hospitalization: Higher MIS values are independently associated with hospitalization and all-cause and cardiovascular death in dialysis cohort studies.

4. Head-to-Head Comparison: MIS vs. 7-Point SGA vs. ISRNM Criteria

To excel on the CDR Specialist in Renal Nutrition (CSR) examination, dietitians must know how and when to deploy these three major assessment tools:

Assessment Instrument Scoring Architecture Parameters Included Primary Clinical Strengths Primary Limitations

Malnutrition Inflammation Score (MIS) Quantitative continuous scale ( 0 to 30 ) across 10 components Medical history, physical exam, BMI, serum albumin, serum TIBC Superior prognostic discrimination for mortality; captures both wasting and inflammation; ideal for tracking response to ONS/IDPN Requires concurrent lab draws (albumin, TIBC); cannot be completed purely at bedside without lab access

7-Point KDOQI SGA Semi-quantitative Likert scale ( 1 to 7 ) based on holistic clinical judgment Medical history (weight, diet, GI, function, stress) and physical exam (fat, muscle, edema) Pure bedside execution without relying on lab values; immune to fluid shifts if dry weight is used; highly validated Qualitative elements create inter-observer variability; lacks objective biochemical/inflammatory markers

ISRNM Consensus PEW Criteria Categorical diagnostic classification ( Must meet ≥ 1 criterion in ≥ 3 of 4 categories ) Serum chemistry (albumin, prealbumin, cholesterol), BMI/weight, muscle mass/MAMC, dietary intake (nPCR, DEI) Establishes formal, internationally standardized diagnostic definition for clinical trials and epidemiology Categorical (Yes/No) format cannot grade subtle severity or track micro-responses to nutrition support

Loading diagram... Architecture of the Malnutrition Inflammation Score (MIS)